Finally, gastric neuroendocrine tumors in Lynch syndrome have not been consistently reported; however, a study of 323 patients with Lynch syndrome underdoing endoscopic surveillance did detect one, with loss of MSH2 protein expression [31]. Here, MSH2 is linked to gastric neuroendocrine tumor, well differentiated, low or intermediate grade.